We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Single Gene Mutation Linked to Severe Atopic Dermatitis

By LabMedica International staff writers
Posted on 05 Jul 2017
A mutation in the CARD11 gene has been linked to the development of the severe allergic skin disease atopic dermatitis (eczema).

The link between the CARD11 mutation and atopic dermatitis was discovered through gene analysis of eight individuals suffering from severe atopic dermatitis from four families. More...
Each of the four families had a distinct mutation that affected a different region of the CARD11 (Caspase recruitment domain-containing protein 11) protein, but all the mutations had similar effects on T-cell signaling.

The CARD11 gene encodes a scaffolding protein involved in lymphocyte receptor signaling. CARDs (Caspase activation and recruitment domains) are interaction motifs found in a wide array of proteins, typically those involved in processes relating to inflammation and apoptosis. These domains mediate the formation of larger protein complexes via direct interactions between individual CARDs. CARD domains are found on a strikingly wide range of proteins, including helicases, kinases, mitochondrial proteins, caspases, and other cytoplasmic factors.

Transfection of the mutant CARD11gene into T-cell lines grown in laboratory culture demonstrated both loss-of-function and dominant-interfering activity upon antigen receptor–induced activation of nuclear factor-kappaB and mammalian target of rapamycin complex 1 (mTORC1). Patient T-cells had similar defects, as well as low production of the cytokine interferon-gamma (IFN-gamma). The mTORC1 and IFN-gamma production defects were partially rescued by supplementation with the amino acid glutamine, which requires CARD11 for import into T-cells.

This study was carried out by the [U.S.] National Institute of Allergy and Infectious Diseases (Bethesda, MD, USA) and was published in the June 19, 2017, online edition of the journal Nature Genetics.

Related Links:
National Institute of Allergy and Infectious Diseases


Gold Member
Fibrinolysis Assay
HemosIL Fibrinolysis Assay Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
HBV DNA Test
GENERIC HBV VIRAL LOAD VER 2.0
Sample Transportation System
Tempus1800 Necto
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Industry

view channel
Image: The LIAISON NES molecular point-of-care platform (Photo courtesy of Diasorin)

Diasorin and Fisher Scientific Enter into US Distribution Agreement for Molecular POC Platform

Diasorin (Saluggia, Italy) has entered into an exclusive distribution agreement with Fisher Scientific, part of Thermo Fisher Scientific (Waltham, MA, USA), for the LIAISON NES molecular point-of-care... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.